AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Homology Medicines, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG024FLKQ79
6.07▼ 1.37 (-18.47%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
7.44
Day's Range
5.61 – 6.51
52-Week Range
5.61 – 15.92
Volume
50.4K
Avg Volume
5,601
Share Statistics
Shares Outstanding
Employees
—
Exchange
XNAS
Listed
—
Share count as of August 3, 2026

Homology Medicines, Inc. Common Stock (FIXX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Homology Medicines, Inc. Common Stock (FIXX)
What is Homology Medicines, Inc. Common Stock's Market Cap?
Homology Medicines, Inc. Common Stock's Market Cap is $180.7M, based on as-reported figures from SEC (XBRL) filings.
What is Homology Medicines, Inc. Common Stock's Enterprise Value?
Homology Medicines, Inc. Common Stock's Enterprise Value is $74.4M, based on as-reported figures from SEC (XBRL) filings.
What is Homology Medicines, Inc. Common Stock's Trailing P/E?
Homology Medicines, Inc. Common Stock's Trailing P/E is 5.3×, based on as-reported figures from SEC (XBRL) filings.
What is Homology Medicines, Inc. Common Stock's Price / Sales?
Homology Medicines, Inc. Common Stock's Price / Sales is 3.4×, based on as-reported figures from SEC (XBRL) filings.
What is Homology Medicines, Inc. Common Stock's EV / Revenue?
Homology Medicines, Inc. Common Stock's EV / Revenue is 1.4×, based on as-reported figures from SEC (XBRL) filings.
What is Homology Medicines, Inc. Common Stock's EV / EBITDA?
Homology Medicines, Inc. Common Stock's EV / EBITDA is 3.4×, based on as-reported figures from SEC (XBRL) filings.
What is Homology Medicines, Inc. Common Stock's Revenue (TTM)?
Homology Medicines, Inc. Common Stock's Revenue (TTM) is $53.7M, based on as-reported figures from SEC (XBRL) filings.
What is Homology Medicines, Inc. Common Stock's Net Income (TTM)?
Homology Medicines, Inc. Common Stock's Net Income (TTM) is $33.8M, based on as-reported figures from SEC (XBRL) filings.
What is Homology Medicines, Inc. Common Stock's EBITDA?
Homology Medicines, Inc. Common Stock's EBITDA is $21.8M, based on as-reported figures from SEC (XBRL) filings.
What is Homology Medicines, Inc. Common Stock's Diluted EPS (TTM)?
Homology Medicines, Inc. Common Stock's Diluted EPS (TTM) is 1.13, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · FIXXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Loss on extinguishment of debt———
Other income (expense), net
Total other income (expense), net
Net loss and comprehensive loss
Net loss per share - basic
Net loss per share - diluted